News

FDA names Dr. Vinay Prasad as top vaccine official
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
Dr. Vinay Prasad to Head FDA Vaccine, Biologics Division
WEDNESDAY, May 7, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a ...
FDA Appointee Is a Notorious Drug Critic With a Lot to Prove
Vinay Prasad oversees vaccines, gene therapies and the blood supply. His views raise alarms for pharmaceutical companies and ...
BioSpace5d
Vinay Prasad’s FDA Appointment ‘Anything but Status Quo’
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and ...
BioPharma Dive5d
Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.
CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...
Vinay Prasad, a critic of drug industry and COVID-19 measures, to lead FDA vaccine program
Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...
The American Journal of Managed Care6d
Biotech Stocks Slide After FDA Selects Prasad to Lead CBER
The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...
FDA names outspoken Covid vaccine critic as the new vaccine chief
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter ...
pharmaphorum6d
Vinay Prasad will replace Marks as CBER director
Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named ...